Timoptic

DRUG2 trials

Sponsors

University of California, Davis, Altheos, Inc.

Conditions

BurnsOcular HypertensionPrimary Open Angle GlaucomaUlcer

Phase 1

Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension

Altheos, Inc.Ocular Hypertension, Primary Open Angle Glaucoma

Start: 2012-01-31Target: 180Updated: 2012-11-01

Phase 2

Beta Blocker for Chronic Wound Healing

TerminatedNCT00368602

University of California, DavisBurns, Ulcer

Start: 2005-06-30End: 2007-06-30Updated: 2015-04-07